Fournier Keith, Rafeeq Safia, Taggart Melissa, Kanaby Paul, Ning Jing, Chen Hsiang-Chun, Overman Michael, Raghav Kanwal, Eng Cathy, Mansfield Paul, Royal Richard
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ann Surg Oncol. 2017 Jan;24(1):187-193. doi: 10.1245/s10434-016-5588-2. Epub 2016 Sep 22.
Low-grade appendiceal mucinous neoplasm of uncertain malignant potential are poorly understood lesions characterized by extraluminal mucin or fibrosis with neoplastic cells confined to the appendiceal lumen. The purpose of this study is to investigate the clinical and pathologic parameters of these lesions to optimize our understanding and management of these tumors.
Subjects with these tumors were identified from the appendiceal tumor databases at the University of Texas MD Anderson Cancer Center. Univariate and multivariate Cox proportional hazards regression analyses assessed relationships between clinicopathologic variables [including age, gender, margin status and serum levels of the tumor markers carcinoembryonic antigen (CEA), cancer antigen (CA)-125, and CA19-9] disease-free survival, postrecurrence survival and overall survival.
Ninety-eight subjects with this disease were identified. Most patients did not experience disease recurrence after initial appendectomy. At last follow-up, 25 (26 %) had disease recurrence or died. Of the 20 patients who had disease recurrence, 5 (25 %) died, and 15 (75 %) were alive. Disease-free survival was significantly reduced with positive margin status (p = 0.02) and elevated serum levels of CEA (p < 0.001), CA19-9 (p = 0.01), or CA-125 (p = 0.002) at the time of appendectomy. The median postrecurrence survival time was 4.7 years and the 5-year postrecurrence survival rate was 41 % (standard error = 18 %).
Patients with Low-grade appendiceal mucinous neoplasm of uncertain malignant potential who have negative margins and normal tumor marker levels have a lower risk for recurrence. In these patients, expectant management is sufficient. Elevated tumor marker levels at the time of appendectomy marks an increased risk of recurrence or death and signals the need for closer monitoring or intervention.
低度恶性潜能的阑尾黏液性肿瘤是一类了解较少的病变,其特征为管腔外黏液或纤维化,肿瘤细胞局限于阑尾管腔内。本研究的目的是调查这些病变的临床和病理参数,以优化我们对这些肿瘤的认识和管理。
从德克萨斯大学MD安德森癌症中心的阑尾肿瘤数据库中识别出患有这些肿瘤的受试者。单因素和多因素Cox比例风险回归分析评估了临床病理变量[包括年龄、性别、切缘状态以及肿瘤标志物癌胚抗原(CEA)、癌抗原(CA)-125和CA19-9的血清水平]与无病生存期、复发后生存期和总生存期之间的关系。
共识别出98例患有这种疾病的受试者。大多数患者在初次阑尾切除术后未出现疾病复发。在最后一次随访时,25例(26%)出现疾病复发或死亡。在20例出现疾病复发的患者中,5例(25%)死亡,15例(75%)存活。阑尾切除时切缘阳性(p = 0.02)以及CEA(p < 0.001)、CA19-9(p = 0.01)或CA-125(p = 0.002)血清水平升高会显著降低无病生存期。复发后中位生存期为4.7年,5年复发后生存率为41%(标准误 = 18%)。
切缘阴性且肿瘤标志物水平正常的低度恶性潜能阑尾黏液性肿瘤患者复发风险较低。对于这些患者,观察等待治疗就足够了。阑尾切除时肿瘤标志物水平升高表明复发或死亡风险增加,提示需要更密切的监测或干预。